Bibcode:1995FEBSL.373..182G
While the pharma industry attempts to expand the improved GLP-1 drug market, including orals, the generics industry will grow its GLP-1 agonist foothold, making cheaper and less efficacious injectable GLP-1 drugs much more widely available, rapidly growing the number of patients comfortable with self-injection for weight loss
pH-temperature responsive hydrogel-mediated delivery of exendin-4 encapsulated chitosan nanospheres for sustained therapeutic efficacy in type 2 diabetes mellitus
Importing peptides from international sources involves additional risk
Designed for GLP-1 users, it contains peptides and nutrients that support healthy, strong hair follicles
Neurally driven hiccups tend to be brief, cluster around specific triggers such as dose changes or meals, and resolve without structural symptoms